| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,281,919 | 1,128,259 | 966,629 | 1,314,996 | | Cost of Revenue | 1,049,323 | 902,261 | 750,077 | 1,065,797 | | | Gross Profit | 232,596 | 225,998 | 216,552 | 249,199 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 231,498 | 228,076 | 222,326 | 232,449 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 10,290 | 9,482 | 9,690 | 13,452 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,192) | (11,560) | (15,464) | 3,298 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 446 | 528 | 844 | 842 | | Earnings Before Interest And Taxes | (8,434) | (10,900) | (14,545) | 4,702 | | Interest Expense | 3,568 | 3,921 | 3,282 | 3,107 | | Income Before Tax | (12,002) | (14,821) | (17,827) | 1,595 | | Income Tax Expense | 235 | 216 | 212 | 238 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,718) | (15,037) | (18,039) | 1,357 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,237) | (15,037) | (18,039) | 1,357 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,237) | ($15,037) | ($18,039) | $1,357 |
|
0.83% Nasdaq 0.00%
Income Statement
